Sentence examples for use of these trial from inspiring English sources
Overall, a wider use of these trial designs might lead to the identification of potential responders, ineffective drugs or combinations, and ultimately contribute to enhance the efficiency of the clinical developmental process.
To make use of these trial data and retain the specific adjustments made by trial statisticians, we have presented our results as odds ratios, with 95% confidence intervals.
Although modestly favoring the adjuvant use of bisphosphonates, these trials failed to provide a clear evidence for their general efficacy in adjuvant therapy.
Very simple low frequency and high frequency approximate solutions are obtained by the use of idealized trial functions, and these compare tolerably well to existing analytical solutions for a variety of geometries.
It is important not to dismiss the large body of evidence on product use from these trials because of a lack of biological measures of adherence.
Another plausible explanation is that the antibodies used in the ELISA had difficulties in detecting the specific strains of salmonella used in these trial sets (S. Worthington and S. Livingstone).
This will further improve bedside use of these markers in future trials.
Despite the widespread use of these indices in clinical trials, their performance as indicators of response in individual RA patients is more problematic [ 1].
Furthermore, evaluation of in vivo antioxidant activity of these fruit extracts has also provided interesting results that might be beneficial for the pharmacological use of these plants in clinical trials.
However, the lack of rigorously validated methods, as well as the documented variability both between and within commonly used Aβ42 assay platforms has impeded the use of these assays in drug trials.
Our results indicate that both the conventional anti-TNF monoclonal antibody treatment and TNF autovaccination are successful in reducing the number and size of lung metastases in this model and supports the use of these agents in clinical trials in patients with metastatic cancer.
